SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-045632
Filing Date
2023-02-23
Accepted
2023-02-23 07:31:41
Documents
5
Effectiveness Date
2023-02-23

Document Format Files

Seq Description Document Type Size
1 S-8 d446122ds8.htm S-8 37245
2 EX-5.1 d446122dex51.htm EX-5.1 7639
3 EX-23.1 d446122dex231.htm EX-23.1 2487
4 EX-FILING FEES d446122dexfilingfees.htm EX-FILING FEES 20167
5 GRAPHIC g446122g0222091318103.jpg GRAPHIC 2737
  Complete submission text file 0001193125-23-045632.txt   72490
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269928 | Film No.: 23655939
SIC: 2836 Biological Products, (No Diagnostic Substances)